Providing market intelligence for more than 35 years

In The News

PayPal’s Popular But Apple Is The Class Favorite

PayPal is the number one mobile payment app in the U.S., according to research by Parks Associates and by quite a margin. NFC World reported that 12 percent of those polled prefer PayPal while retail-branded apps are second at 9 percent and Apple Pay is at 4 percent. But it’s a bit of a mystery then why merchants are requesting Apple Pay much more than PayPal for in-store payments. A huge 67 percent are requesting Apple Pay versus 8 percent requesting PayPal.

Chris Tweedt, research analyst at Parks Associates, said: “While PayPal is the clear market share leader, more merchants are requesting information from Apple Pay than any other mobile payment solution.” Tweedt added, “Apple has added a Pay with Apple Pay button into its Safari browser and the company has signed up 21 of the top 100 online merchants, with others to come.”

From the article "PayPal’s Popular But Apple Is The Class Favorite" by PYMNTS.

Previously In The News

Cord Cutters Face A Sea Of Streaming Options

Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

TV Everywhere Usage Grows

A recent article in Multichannel News provided new findings from Parks Associates showing that 40 percent of U.S. pay TV subscribers used TV Everywhere options in 2015, up from 22 percent in 2013. "TV...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...